Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | DBH | P09172 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27441451 | 0.81 | PLK1 (0.35) | CA1CA2CA7CA9KDM4E | |
| SCHEMBL727644 | 0.79 | CFTR (0.40) | KDM4EMEN1ALDH1A1TP53CYP3A4 | |
| Benzoic Acid SCHEMBL28982995 | 0.72 | GAA (0.43) | MEN1CYP3A4ALOX15MAPK1KMT2A | |
| SCHEMBL28763488 | 0.71 | GAA (0.40) | KDM4EMEN1MAPTKMT2ATDP1 | |
| SCHEMBL4654217 | 0.71 | DBH (0.35) | CA1CA2CA7CA9MMP2 | |
| SCHEMBL5154627 | 0.69 | NPC1 (0.32) | CA2KDM4EMEN1ALDH1A1CYP3A4 | |
| SCHEMBL30727395 | 0.69 | NPC1 (0.32) | CA2KDM4EMEN1ALDH1A1CYP3A4 | |
| SCHEMBL28684184 | 0.68 | — | — | |
| Cinnamic Acid SCHEMBL28983011 | 0.67 | HCAR2 (0.47) | CA1CA2CA7CA9KDM4E | |
| SCHEMBL28998304 | 0.67 | EDNRA (0.32) | KDM4EMEN1TP53MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | claimed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | claimed |
| CN-1990482-B | Flavanonol compounds and their production method and use | ZHEJIANG HISUN PHARM CO LTD | 2010-12-08 | — | — | CN | claimed |
| CN-1990482-A | Flavanonol compounds and their production method and use | ZHEJIANG HISUN NATURELITE PHAR (CN) | 2007-07-04 | — | — | CN | claimed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| CN-115850295-A | Preparation method and application of diketone compound dysosma versipellis biflavone A-E | 河南中医药大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-114957362-A | Separation method of anti-inflammatory active ingredients of coreopsis tinctoria | 中国科学院西北高原生物研究所 | 2022-08-30 | — | — | CN | disclosed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | disclosed |
| EP-3982916-A1 | DYE COMPOSITION COMPRISING A COMBINATION OF TWO PLANT EXTRACTS OF LAWSONIA INERMIS | Pierre Fabre Dermo-Cosmétique (FR) | 2022-04-20 | — | — | EP | disclosed |
| US-11207265-B2 | Extract of the aerial parts of Lawsonia inermis and its preparation method | PIERRE FABRE DERMO-COSME FIQUE (FR) | 2021-12-28 | — | — | US | disclosed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | disclosed |
| CN-1097073-C | Polymer composition and resist meterial | WAKO PURE CHEM IND LTD (JP) | 2002-12-25 | — | — | CN | disclosed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | disclosed |
| CN-1313765-A | Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents | LAFON L (FR) | 2001-09-19 | — | — | CN | disclosed |
| EP-1024406-A1 | Resist composition | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 2000-08-02 | — | — | EP | disclosed |
| US-5976759-A | ALKALI SOLUBLE BY HEATING | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-11-02 | — | — | US | disclosed |
| CN-1159459-A | Polymer composition and resist meterial | WAKO PURE CHEM IND LTD (JP) | 1997-09-17 | — | — | CN | disclosed |
| EP-0780732-A2 | Polymer composition and resist material | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1997-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207265-B2 | Extract of the aerial parts of Lawsonia inermis and its preparation method | KRT18, MKI67, CD68 | CA1 1160/4885CA2 2044/4885CA7 495/4885 |
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | CA1 986/4885CA2 796/4885CA7 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.